Navigation Links
Medicinal chemist wins inaugural De Burgh Fellowship
Date:11/11/2010

Medicinal chemist Dr Guillaume Lessene has been awarded the Walter and Eliza Hall Institute's inaugural de Burgh Fellowship at the institute's annual general meeting in Melbourne, Australia.

The $AUD150,000 de Burgh Fellowship honours the role Professor Patrick de Burgh played in shaping the Walter and Eliza Hall Institute. It was established this year following the death of Professor de Burgh in August at the age of 94.

It was in Professor de Burgh's laboratory at the University of Sydney that institute legends Professor Donald Metcalf, Professor Jacques Miller and Sir Gustav Nossal obtained their first taste of research.

Professor de Burgh was a Bosch Professor or Bacteriology at the University of Sydney and worked on the pathogenesis of infectious disease.

Dr Lessene said it was a great honour to be named the de Burgh Fellow. "The fact the fellowship acknowledges translational research is really important that is what I do every day and it's great that these activities are supported by the fellowship and the institute," Dr Lessene said.

Dr Lessene translates research findings from the institute into the discovery and development of new drugs. His main focus is cancer research and Dr Lessene is currently working on developing inhibitors to the pro-survival Bcl-2 proteins that are involved in programmed cell death, for treatment of several types of cancer. He is also involved in projects looking at other cancer targets, such as tyrosine kinases, and non-cancer targets involved in conditions such as Alzheimer's disease.

"We work in multidisciplinary teams in constant interaction with biologists to create small molecules that will interact with or modulate recognised cell signaling pathways or targets involved in disease, with the aim of treating or curing that disease," Dr Lessene said.

"The very high standing of the research at the institute is a key element in the success of our program. The Chemical Biology division of which I am part is there to take the next step, bringing these biological discoveries from the laboratory and translating them into molecules that have the right biological activities and properties to reach clinical trials and potentially become a new drug."

Institute director Professor Doug Hilton congratulated Dr Lessene and said the institute and the Australian community owed Professor de Burgh a great debt.

"One could only imagine the shape of Australian medical research today had Professor de Burgh provided a humdrum rather than an inspiring environment," Professor Hilton said.

"The De Burgh Fellowship is awarded to a scientist with an outstanding record of research or research translation, who collaborates productively with other members of the faculty, and who is likely to make a major contribution to the institute in the long term. Guillaume meets all these criteria with aplomb."


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Medicinal cannabis review highlights dilemmas facing health care professionals
2. Pfizer joins open-access medicinal chemistry public-private collaboration
3. St. Johns wort collection mined for its medicinal value
4. MIT chemists engineer plants to produce new drugs
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. Biochemist studies DNA repair with $787,000 in grants
7. MIT moves toward greener chemistry
8. Basque researchers apply chemistry to restoration of paintings and dating of signatures
9. Subtyping breast cancer by immunohistochemistry to investigate survival terms
10. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
11. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicinal chemist wins inaugural De Burgh Fellowship
(Date:5/27/2017)... Los Angeles, California (PRWEB) , ... May 26, 2017 , ... ... Canadian senior citizens who visit a doctor for colds or respiratory issues that are ... note that excessive time pressure on doctors may be largely responsible for the problem ...
(Date:5/27/2017)... Rosa, CA (PRWEB) , ... May 27, 2017 , ... ... cause for concern, but a new study from the Osteoarthritis Initiative shows ... to developing knee osteoarthritis. Knowing this in advance may give doctors the opportunity to ...
(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... focusing on the Peace Agreements being discussed by President Donald Trump and the rest ... to try to speed up peace talks in the continuous battle between Israel and ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
Breaking Medicine Technology: